Infliximab Maintenance Home Infusion Appears Safe
(MedPage Today) -- ORLANDO – Maintenance doses of the biologic agent infliximab (Remicade) can be safely administered at a patient's home with a very low rate of adverse events (AEs) and serious AEs, a researcher reported here.
Of 863 patients...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Gastroenterology | Remicade